Comments on: FDA Snarls At Lilly Ads For New Dog Drug http://www.pharmalot.com/2007/07/fda-snarls-at-lilly-ads-for-dog-drug/ News, Comment and Conversation Fri, 10 Feb 2012 19:25:13 +0000 http://wordpress.org/?v=2.6.2 By: Laurie http://www.pharmalot.com/2007/07/fda-snarls-at-lilly-ads-for-dog-drug/#comment-15040 Laurie Tue, 10 Jul 2007 17:09:07 +0000 http://www.pharmalot.com/2007/07/fda-snarls-at-lilly-ads-for-dog-drug/#comment-15040 No surprise here. Withholding critical information about a drugs effectivness is normal operating procedure for the pharmaceuticals. No surprise here. Withholding critical information about a drugs effectivness is normal operating procedure for the pharmaceuticals.

]]> By: John Mack http://www.pharmalot.com/2007/07/fda-snarls-at-lilly-ads-for-dog-drug/#comment-15023 John Mack Tue, 10 Jul 2007 14:13:31 +0000 http://www.pharmalot.com/2007/07/fda-snarls-at-lilly-ads-for-dog-drug/#comment-15023 The FDA might as well smack Lilly across the nose with a newspaper for all the good that this "untitled" -- not even warning -- letter will do. I wonder how many doggie DTC ad regulators there are compared to human DTC ad regulators? Will some PDUFA funds go to hiring more of the former as well as the latter? The FDA might as well smack Lilly across the nose with a newspaper for all the good that this “untitled” — not even warning — letter will do.

I wonder how many doggie DTC ad regulators there are compared to human DTC ad regulators? Will some PDUFA funds go to hiring more of the former as well as the latter?

]]>